SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 129 filers reported holding SCICLONE PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $9,484,000 | -7.6% | 846,803 | -9.2% | 0.03% | -8.1% |
| Q2 2017 | $10,259,000 | +346.8% | 932,675 | +298.0% | 0.04% | +362.5% |
| Q1 2017 | $2,296,000 | +15.4% | 234,328 | +27.2% | 0.01% | 0.0% |
| Q4 2016 | $1,989,000 | -0.5% | 184,178 | -5.5% | 0.01% | +14.3% |
| Q3 2016 | $1,998,000 | +95.7% | 194,944 | +149.3% | 0.01% | +75.0% |
| Q2 2016 | $1,021,000 | +325.4% | 78,189 | +258.4% | 0.00% | +300.0% |
| Q1 2016 | $240,000 | -80.5% | 21,819 | -83.7% | 0.00% | -83.3% |
| Q4 2015 | $1,229,000 | +550.3% | 133,575 | +389.3% | 0.01% | +500.0% |
| Q3 2015 | $189,000 | -87.6% | 27,300 | -82.5% | 0.00% | -85.7% |
| Q2 2015 | $1,529,000 | -22.3% | 155,738 | -29.9% | 0.01% | -30.0% |
| Q1 2015 | $1,969,000 | +18.3% | 222,265 | +16.9% | 0.01% | +11.1% |
| Q4 2014 | $1,665,000 | -22.4% | 190,116 | -39.0% | 0.01% | -10.0% |
| Q3 2014 | $2,147,000 | +327.7% | 311,673 | +226.6% | 0.01% | +400.0% |
| Q2 2014 | $502,000 | +76.8% | 95,442 | +53.1% | 0.00% | 0.0% |
| Q1 2014 | $284,000 | -55.5% | 62,349 | -50.8% | 0.00% | -50.0% |
| Q4 2013 | $638,000 | +64.0% | 126,658 | +64.9% | 0.00% | +100.0% |
| Q3 2013 | $389,000 | -25.6% | 76,800 | -27.2% | 0.00% | -50.0% |
| Q2 2013 | $523,000 | – | 105,438 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|